Literature DB >> 25819781

Understanding Miltefosine-Membrane Interactions Using Molecular Dynamics Simulations.

Matheus Malta de Sá1,2, Vishnu Sresht1, Carlota Oliveira Rangel-Yagui2, Daniel Blankschtein1.   

Abstract

Coarse-grained molecular dynamics simulations are used to calculate the free energies of transfer of miltefosine, an alkylphosphocholine anticancer agent, from water to lipid bilayers to study its mechanism of interaction with biological membranes. We consider bilayers containing lipids with different degrees of unsaturation: dipalmitoylphosphatidylcholine (DPPC, saturated, containing 0%, 10%, and 30% cholesterol), dioleoylphosphatidylcholine (DOPC, diunsaturated), palmitoyloleoylphosphatidylcholine (POPC, monounsaturated), diarachidonoylphosphatidylcholine (DAPC, polyunsaturated), and dilinoleylphosphatidylcholine (DUPC, polyunsaturated). These free energies, calculated using umbrella sampling, were used to compute the partition coefficients (K) of miltefosine between water and the lipid bilayers. The K values for the bilayers relative to that of pure DPPC were found to be 5.3 (DOPC), 7.0 (POPC), 1.0 (DAPC), 2.2 (DUPC), 14.9 (10% cholesterol), and 76.2 (30% cholesterol). Additionally, we calculated the free energy of formation of miltefosine-cholesterol complexes by pulling the surfactant laterally in the DPPC + 30% cholesterol system. The free energy profile that we obtained provides further evidence that miltefosine tends to associate with cholesterol and has a propensity to partition into lipid rafts. We also quantified the kinetics of the transport of miltefosine through the various bilayers by computing permeance values. The highest permeance was observed in DUPC bilayers (2.28 × 10(-2) m/s) and the lowest permeance in the DPPC bilayer with 30% cholesterol (1.10 × 10(-7) m/s). Our simulation results show that miltefosine does indeed interact with lipid rafts, has a higher permeability in polyunsaturated, loosely organized bilayers, and has higher flip-flop rates in specific regions of cellular membranes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25819781     DOI: 10.1021/acs.langmuir.5b00178

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  5 in total

1.  Attenuating Staphylococcus aureus Virulence by Targeting Flotillin Protein Scaffold Activity.

Authors:  Gudrun Koch; Charlotte Wermser; Ivan C Acosta; Lara Kricks; Stephanie T Stengel; Ana Yepes; Daniel Lopez
Journal:  Cell Chem Biol       Date:  2017-06-29       Impact factor: 8.116

2.  Singular Interaction between an Antimetastatic Agent and the Lipid Bilayer: The Ohmline Case.

Authors:  Fernando E Herrera; Charlotte M Sevrain; Paul-Alain Jaffrès; Hélène Couthon; Axelle Grélard; Erick J Dufourc; Aurélie Chantôme; Marie Potier-Cartereau; Christophe Vandier; Ana M Bouchet
Journal:  ACS Omega       Date:  2017-10-04

Review 3.  Reviewing the Effects of Miltefosine and Suggesting It for the Treatment of Coronavirus Disease (COVID-19).

Authors:  Alireza Latifi
Journal:  Infect Dis (Auckl)       Date:  2020-12-01

4.  Characterizing the non-linear pharmacokinetics of miltefosine in paediatric visceral leishmaniasis patients from Eastern Africa.

Authors:  Semra Palić; Anke E Kip; Jos H Beijnen; Jane Mbui; Ahmed Musa; Alexandra Solomos; Monique Wasunna; Joseph Olobo; Fabiana Alves; Thomas P C Dorlo
Journal:  J Antimicrob Chemother       Date:  2020-11-01       Impact factor: 5.790

5.  The anti-parasitic drug miltefosine suppresses activation of human eosinophils and ameliorates allergic inflammation in mice.

Authors:  Eva Knuplez; Melanie Kienzl; Athina Trakaki; Rudolf Schicho; Akos Heinemann; Eva M Sturm; Gunther Marsche
Journal:  Br J Pharmacol       Date:  2021-02-02       Impact factor: 9.473

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.